ArticleThe Journal of investigative dermatology2022

EZH2 Inhibitor Enhances the STING Agonist‒Induced Antitumor Immunity in Melanoma.

Tianxiao Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.